.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
Daycare chemotherapy is rapidly becoming the standard for cancer treatment across Karnataka's government and private hospitals. Specifically, nearly 80% of patients now receive their infusion therapies without needing overnight hospitalization. This shift significantly reduces the burden on tertiary care centers like the Kidwai Memorial Institute of Oncology. Consequently, patients can access high-quality treatment closer to their homes. Furthermore, the daycare model supports better bed management and lowers overall healthcare costs for both providers and patients.
Doctors highlight several clinical benefits associated with the outpatient delivery of cancer drugs. Primarily, shorter infusion times and improved drug tolerability allow patients to return home the same day. This approach minimizes disruptions to daily life and fosters a more comfortable recovery environment. Additionally, the risk of hospital-acquired infections decreases when patients spend less time in a traditional inpatient setting. However, medical teams still reserve inpatient care for roughly 10% of complex cases, such as leukemia or severe sarcoma. Thus, the model provides a balanced approach to modern oncology by prioritizing efficiency for the majority.
The Karnataka government established 16 District Daycare Chemotherapy Centres (DDCCs) in June 2025 to decentralize cancer care effectively. These centers follow a hub-and-spoke model where primary centers refer complex queries to specialist institutes for guidance. For instance, the Mysuru District Hospital has successfully treated dozens of patients through multiple cycles without requiring transfers to the capital. This decentralization ensures that patients from rural areas do not have to travel long distances for routine sessions. Moreover, the state plans to expand this network to further improve clinical adherence and long-term patient outcomes across the region.
Q1: What are the main benefits of daycare chemotherapy for patients?
Daycare chemotherapy offers lower treatment costs, a reduced risk of hospital-acquired infections, and the comfort of recovering at home with family support.
Q2: Who is eligible for daycare treatment versus inpatient admission?
Most oncology patients are eligible for daycare services; however, complex cases like leukemia or patients requiring intensive side-effect monitoring still need inpatient admission.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or replace professional judgment. Refer to the latest local and national guidelines for clinical practice.
References
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
Karnataka's shift to daycare chemotherapy reduces inpatient stays, cuts costs, and improves patient comfort through an expanded hub-and-spoke model....
5 months ago
Dendritic cells bridge innate and adaptive immunity in myocardial infarction. This review explores their pathological roles, circulating dynamics, novel tolerogenic interventions, and how standard cardiovascular medications modulate dendritic cells to improve post-infarction myocardial repair and patient outcomes.
Today
A premature neonate developed upper limb compartment syndrome after uterine rupture extruded the arm through a scar defect. Conservative management with continuous monitoring yielded complete functional recovery and normal limb growth at 10-year follow-up, highlighting non-operative safety in selected cases.
Today
Atherosclerosis involves extensive glycometabolic reprogramming across immune and vascular cells. This review examines how glycolysis, the pentose phosphate pathway, and lactate-driven epigenetic shifts fuel plaque vulnerability, while highlighting novel therapeutic targets like PFKFB3 and LDHA.
Today
Endoscopic posterior cervical fusion combines minimally invasive decompression, joint preparation, and rigid screw-rod fixation for atlantoaxial pathologies. Early clinical findings demonstrate solid bony union, excellent symptom relief, and minimal soft-tissue morbidity without significant vascular compromise.
Yesterday
The All-India Food Processors' Association has approached the Supreme Court to oppose FSSAI's proposed per-100g benchmark for front-of-pack warning labels, advocating instead for a per-serving threshold. We explore the regulatory showdown, nutritional evidence, and implications for clinical lifestyle counseling.
Today
